Our Portfolio Companies
We invest in companies enabling the future of biotechnology, immunotherapy and life sciences.
ACCELERATing the USE OF STEM CELLS for regenerative medicine
RoosterBio is accelerating the field of regenerative medicine and disrupting the market by radically simplifying human mesenchymal stem/stromal cell (hMSC) biomanufacturing and supply.
RNA Splicing Analytics + Artificial Intelligence for Drug Discovery
Envisagenics' mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence.
Acoustic Cell handling
FloDesign Sonics' acoustic technology is unique, disruptive, and broad-based. FDS is set to disrupt bioprocessing and immunotherapy delivery.